Hannibal Clinic

Hannibal, Missouri 63401

0 studies enrolling now · 8 studies all time

What they study most

AATD, Alpha 1-Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency, Alpha1-antitrypsin Deficiency, COVID-19, Community-acquired Pneumonia, Emphysema, Idiopathic Pulmonary Fibrosis, Rheumatoid Arthritis

Studies at this site

• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Recruiting now
• Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema — Completed
• Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Paused
• Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis — Completed
• Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) — Stopped early
• Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency — Completed
• GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study — Completed
• A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) — Completed